The International Congress on Industrial Hemp and Medical Cannabis Concludes with Strong Participation

The International Congress on Industrial Hemp and Medical Cannabis successfully concluded after two intensive days of activity, bringing together a broad and diverse group of participants from across Argentina. The event, which generated high levels of interest and attendance, was coordinated by Dr. Silvia Kochen and Dr. Marcelo Morante—two leading figures in the country’s scientific and medical cannabis space.

Their efforts culminated in a congress that not only attracted widespread participation but also underscored the growing national momentum behind the development of cannabis and industrial hemp.

Held with the clear objective of promoting the scientific, medical, productive, and social advancement of cannabis and industrial hemp, the congress created an inclusive space where specialists, healthcare professionals, researchers, representatives of organizations, and civil society actors could come together to share knowledge and strategies. The gathering emphasized the importance of an interdisciplinary and evidence-based approach to cannabis and hemp policy in Argentina.

A Milestone Event Unites Experts, Institutions, and Civil Society to Advance Argentina’s Scientific and Inclusive Cannabis and Hemp Agenda

More than 1,500 people attended the event, reflecting the strong and growing interest in the subject across different sectors. The congress featured the active involvement of 13 national universities, 11 provinces, 10 municipalities, and 21 non-governmental organizations, demonstrating a truly federal and multisectoral effort. International experts were also in attendance, contributing global perspectives and best practices to enrich the local debate and development efforts.

Throughout the two days, participants took part in a wide range of activities designed to foster dialogue, education, and collaboration. These included roundtable discussions led by experts, keynote lectures by renowned specialists, and open forums for discussion. Attendees also had the opportunity to explore the latest research through presentations of scientific papers and posters.

Additionally, specialized workshops were held on topics such as cannabis and hemp cultivation techniques, the formulation of master blends, clinical trial design, and the production of both medicinal and industrial derivatives.

One of the most anticipated and celebrated moments of the congress was the award ceremony recognizing the best scientific paper. This honor was awarded to Manuela Villanueva for her outstanding research on clinical trials related to the use of medicinal cannabis. Her paper, titled “Experience with the use of cannabidiol as an adjuvant treatment in adult patients with refractory focal epilepsy,” was praised for its valuable contribution to both scientific understanding and clinical practice.

The study highlights how cannabidiol can serve as a supportive treatment for patients with epilepsy who do not respond to traditional therapies, offering new hope in a challenging medical area.

Villanueva’s recognition was met with enthusiastic applause and served as a testament to the importance of continued research in this evolving field. Her work stood out among numerous high-quality submissions, signaling a growing body of academic interest in cannabis and hemp studies in Argentina.

The congress ultimately represents a crucial milestone in the national development of cannabis and industrial hemp. It not only promoted the exchange of knowledge and innovation but also laid the groundwork for more robust and cohesive public policies. By emphasizing the need for science-based decision-making, the event contributed to the strengthening of cross-sector networks and the construction of a sustainable, inclusive federal agenda.

As Argentina moves forward, the momentum generated by this congress will play a key role in shaping the future of cannabis and hemp development. The event demonstrated a clear commitment to building a framework that integrates scientific research, healthcare innovation, responsible production, and social inclusion—placing Argentina among the countries seeking to lead with informed, ethical, and sustainable cannabis policies.

__

(Featured image by Terrance Barksdale via Pexels)

DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.

This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.

First published in ENYS. A third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.

Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Born2Invest assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Born2Invest is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.